EFFICACY AND SAFETY OF INTRAVENOUS GOLIMUMAB IN PATIENTS WITH JUVENILE IDIOPATHIC ARTHRITIS: RESULTS FROM A PHASE 3 OPEN-LABEL STUDY

被引：0
|
作者：
Spindler, Alberto [1 ]
Ruperto, Nicola [2 ]
Pacheco Tena, Cesar Francisco [3 ]
Louw, Ingrid [4 ]
Vega-Cornejo, Gabriel [5 ]
Kingsbury, Daniel [6 ]
Clark, Michael [7 ]
Bensley, Karen [7 ]
Li, Xiaoming [7 ]
Brunner, Hermine [8 ]
机构：
[1] Ctr Med Privado Reumatol, San Miguel De Tucuman, Tucuman, Argentina
[2] Ist Giannina Gaslini, Pediat II, Reumatol, PRINTO Coordinating Ctr, Genoa, Italy
[3] Univ Autonoma Chihuahua, Circuito Univ Campus 2, Chihuahua, Mexico
[4] Panorama Med Ctr, Cape Town, South Africa
[5] Hosp Mexico Amer, Guadalajara, Jalisco, Mexico
[6] Legacy Emanuel, Randall Childrens Hosp, Portland, OR USA
[7] Janssen Res & Dev LLC, Spring House, PA USA
[8] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH 45229 USA
来源：
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 2019年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
323
引用
收藏
页码：S11 / S11
页数：1
相关论文
共 50 条
  • [41] DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
    Fabi, Sabrina G.
    Cohen, Joel L.
    Green, Lawrence J.
    Dhawan, Sunil
    Kontis, Theda C.
    Baumann, Leslie
    Gross, Todd M.
    Gallagher, Conor J.
    Brown, Jessica
    Rubio, Roman G.
    [J]. DERMATOLOGIC SURGERY, 2021, 47 (01) : 48 - 54
  • [42] Intravenous Lacosamide in Pediatric Status Epilepticus: An Open-Label Efficacy and Safety Study
    Poddar, Karan
    Sharma, Rohan
    Ng, Yu-Tze
    [J]. PEDIATRIC NEUROLOGY, 2016, 61 : 83 - 86
  • [43] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun-Bong
    Genovese, Mark
    [J]. JOURNAL OF RHEUMATOLOGY, 2018, 45 (07) : 1035 - 1035
  • [44] Efficacy and Safety of Switching from Adalimumab to Sarilumab in an Open-Label Extension of a Phase 3 Monotherapy Trial in Patients with Active Rheumatoid Arthritis
    Burmester, Gerd R.
    Fiore, Stefano
    Hu, Chih-Chi
    Fay, Jonathan
    Lee, Eun Bong
    Genovese, Mark C.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [45] Safety and Efficacy of Subcutaneous Tocilizumab in Systemic Sclerosis: Results from the Open-Label Period of a Phase 3 Trial
    Khanna, Dinesh
    Lin, Celia J. F.
    Spotswood, Helen
    Siegel, Jeffrey
    Furst, Daniel
    Denton, Christopher
    [J]. ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [46] Safety and Efficacy of Filgotinib: Up to 4-year Results From an Open-label Extension Study of Phase II Rheumatoid Arthritis Programs
    Kavanaugh, Arthur
    Westhovens, Rene R.
    Winthrop, Kevin L.
    Lee, Susan J.
    Tan, YingMeei
    An, Di
    Ye, Lei
    Sundy, John S.
    Besuyen, Robin
    Meuleners, Luc
    Stanislavchuk, Mykola
    Spindler, Alberto J.
    Greenwald, Maria
    Alten, Rieke
    Genovese, Mark C.
    [J]. JOURNAL OF RHEUMATOLOGY, 2021, 48 (08) : 1230 - 1238
  • [47] Efficacy and safety of open-label etanercept on extended oligoarticular juvenile idiopathic arthritis, enthesitis-related arthritis and psoriatic arthritis: part 1 (week 12) of the CLIPPER study
    Horneff, Gerd
    Burgos-Vargas, Ruben
    Constantin, Tamas
    Foeldvari, Ivan
    Vojinovic, Jelena
    Chasnyk, Vyacheslav G.
    Dehoorne, Joke
    Panaviene, Violeta
    Susic, Gordana
    Stanevica, Valda
    Kobusinska, Katarzyna
    Zuber, Zbigniew
    Mouy, Richard
    Rumba-Rozenfelde, Ingrida
    Breda, Luciana
    Dolezalova, Pavla
    Job-Deslandre, Chantal
    Wulffraat, Nico
    Alvarez, Daniel
    Zang, Chuanbo
    Wajdula, Joseph
    Woodworth, Deborah
    Vlahos, Bonnie
    Martini, Alberto
    Ruperto, Nicolino
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (06) : 1114 - 1122
  • [48] Long-term treatment of systemic juvenile idiopathic arthritis with tocilizumab: results of an open-label extension study in Japan
    Yokota, Shumpei
    Imagawa, Tomoyuki
    Mori, Masaaki
    Miyamae, Takako
    Takei, Syuji
    Iwata, Naomi
    Umebayashi, Hiroaki
    Murata, Takuji
    Miyoshi, Mari
    Tomiita, Minako
    Nishimoto, Norihiro
    Kishimoto, Tadamitsu
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (04) : 627 - 628
  • [49] Efficacy of repeated intravenous infusions of an anti-tumor necrosis factor α monoclonal antibody, infliximab, in persistently active, refractory juvenile idiopathic arthritis -: Results of an open-label prospective study
    Gerloni, V
    Pontikaki, I
    Gattinara, M
    Desiati, F
    Lupi, E
    Lurati, A
    Salmaso, A
    Fantini, F
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (02): : 548 - 553
  • [50] Efficacy and Safety of Tocilizumab in Patients with Polyarticular Juvenile Idiopathic Arthritis: Data From a Phase 3 Trial.
    Brunner, Hermine
    Ruperto, Nicolino
    Zuber, Zbigniew
    Keane, Caroline
    Harari, Olivier
    Kenwright, Andrew
    Cuttica, Ruben J.
    Keltsev, Vladimir
    Xavier, Ricardo
    Penades, Inmaculada Calvo
    Nikishina, Irina
    Rubio-Perez, Nadina
    Alekseeva, Ekaterina
    Chasnyk, Vyacheslav
    Chavez, Jose
    Horneff, Gerd
    Opoka-Winiarska, Violetta
    Quartier, Pierre
    Silva, Clovis A.
    Silverman, Earl D.
    Spindler, Alberto
    Lovell, D. J.
    Martini, Alberto
    De Benedetti, Fabrizio
    [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S682 - S682
12345